July 3, 2015
font size

Pancreatic Cancer (cont.)

Medical Author:
Medical Author:
Medical Author:
Medical Editor:

What research is being done on pancreatic cancer?

Doctors and researchers all over the world are hard at work developing better treatments for pancreatic cancer. Cooperative research led by centers of excellence in this country and many others continue daily to test new surgical techniques, radiation strategies, chemotherapy agents, and alternative therapies in an effort to improve care. Given the slow progress experienced over the last quarter century, many doctors feel that every eligible patient with pancreatic cancer should be offered enrollment in a research trial. New cytotoxic combinations of drugs are being tried in clinical trials. For example, Folfirinox, a new combination regimen consisting of four different chemicals has shown increase survival times for patients in clinical trials. In addition, two vaccines, GVAX and CRS-207, showed about a doubling of survival time compared to patients that did not receive the vaccine; this vaccine protocol is still undergoing clinical trials. For a complete list of clinical trials in pancreatic cancer treatment, please check online at http://www.cancer.gov.

Is complimentary or alternative medicine effective in pancreatic cancer treatment?

Complimentary or alternative medicine is of unclear benefit in pancreatic cancer treatment. No specific complimentary or alternative therapy has been proven beneficial, but many adjunctive treatments have been tried. Compounds such as curcumin, the principle ingredient in turmeric, have shown efficacy in nonhuman research and are being tested in clinical trials in pancreatic cancer. Given the modest benefit derived from chemotherapy and radiation in this disease, alternative approaches in the treatment of pancreatic cancer in conjunction with (rather than instead of) standard treatment is warranted.

Is it possible to prevent pancreatic cancer?

At this time, there is no known surveillance strategy to reduce the risk of pancreatic cancer for the general population. With only 46,000 new diagnoses a year, screening blood tests or X-rays have never been proven to be cost effective or beneficial. Additionally, doctors do not routinely screen individuals with family members diagnosed with pancreatic cancer aside from the rare instance where a known genetic risk factor is present.

Medically Reviewed by a Doctor on 5/29/2015

Source: MedicineNet.com
http://www.medicinenet.com/pancreatic_cancer/article.htm

Cancer

Get the latest treatment options.

Pancreatic Cancer Related Articles
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations